Tech Company Financing Transactions
TP Therapeutics Funding Round
On 3/22/2016, TP Therapeutics raised $18 million in investment from private investors.
Transaction Overview
Company Name
Announced On
3/22/2016
Transaction Type
Venture Equity
Amount
$17,979,732
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. 26 investors participated in the offering. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10628 Science Center Dr. 225
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
TP Therapeutics, Inc. is a structure-based drug design company headquartered in San Diego, California. TP is focusing on the discovery and development of precision medicines for cancer and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jean Cui
Chief Executive Officer
Athena Countouriotis
Co-Founder
Yishan Li
Vice President
Armin Graber
Vice President
Jeffrey Whitten
VP - Finance
Brian Baker
VP - Operations
Miriam Cruz
VP - Operations
Yuelie Lu
VP - Regulatory Affairs
John Lim
VP - Regulatory Affairs
Naresh Nayyar
Browse more venture capital transactions:
Prev: 3/21/2016: Moat venture capital transaction
Next: 3/22/2016: LogFire venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs